REGENXBIO, Inc. (RGNX)
10.31
-0.02
(-0.19%)
USD |
NASDAQ |
Feb 09, 16:00
8.88
-1.43
(-13.87%)
After-Hours: 05:38
REGENXBIO Accounts Payable (Quarterly) : 22.27M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Omeros Corp. | 12.50M |
| Sarepta Therapeutics, Inc. | 94.02M |
| AbbVie, Inc. | -- |
| CytomX Therapeutics, Inc. | 0.646M |
| Krystal Biotech, Inc. | 2.097M |